4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-23-038808
Options or other derivatives
- Director acquired 47,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2023-06-16 | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | I | ||
| BAKER BROS. ADVISORS LP Director | 2023-06-16 | Grant or award · Non- Qualified Stock Option (right to buy) | +23,500 | 23,500 | I | ||
Loading xslF345X04/doc4.xml…